Using Virtual Reality to Teach Mindfulness to People With Migraine

NCT ID
NCT07599228
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Brigham and Women's Hospital
Conditions
Episodic Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Migraine Intervention Using Reality-Assisted Guided Experience

Enrollment: 160 participants (Estimated).

What is being studied

  • Behavioral: ACT therapy delivered by REACT NeuroVR headset

Who may be eligible

Ages
18 Years to 80 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Adults aged 18-80 * Diagnosed with episodic migraine and experience 4-10 migraine days/month * On a stable dose of CGRP mAb for three months prior * Satisfy 4 week run-in of 4-10 headaches/month * Not taking other preventive medications * Not pregnant, breastfeeding, or planning to become pregnant within study timeframe * Able and willing to use VR device * No history of significant psychiatric illness * Willing to comply with study procedures * English-speaking Exclusion Criteria: * Medication overuse (\>10 days/month) * Vertigo/vestibular dysfunction * Active psychiatric or neurological comorbidities * Pregnancy, breastfeeding or planning pregnancy within study timeframe * Significant visual/hearing/mobility impairment affecting VR use

Study locations

3 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Massachusetts, United States: 3

Sample of listed locations

  • Brigham and Womens Hospital — Boston, Massachusetts, 02155, United States — Site recruitment status not specified in the registry data
  • Brigham and Women's Health Care Center — Chestnut Hill, Massachusetts, 02467, United States — Site recruitment status not specified in the registry data
  • Brigham and Women's Hospital — Chestnut Hill, Massachusetts, 02467, United States — Site recruitment status not specified in the registry data

Study details

Start date
September 30, 2026
Primary completion date
August 1, 2029
Completion date
January 1, 2031
First posted
May 20, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07599228
Registry last updated
September 30, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07599228 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Migraines studies | Clinical trial FAQ